TY  - GEN
AU  - Wais,V
AU  - Kündgen,L
AU  - Bohl,S R
AU  - von Harsdorf,S
AU  - Schlenk,R F
AU  - Döhner,K
AU  - Teleanu,V
AU  - Bullinger,L
AU  - Nguyen,T M
AU  - Drognitz,K
AU  - Moulin,J-C
AU  - Binnenhei,M
AU  - Bentz,M
AU  - Döhner,H
AU  - Bunjes,D
AU  - Kuchenbauer,F
AU  - Ringhoffer,M
TI  - Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome
SN  - 1476-5365
PY  - 2019///0308
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Carmustine
KW  - Comorbidity
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - methods
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Melphalan
KW  - Neoplasm Staging
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - analogs & derivatives
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bmt.2017.211
ER  -